What IC-Green Assesses: Main Uses and Clinical Clarity

Indocyanine Green (IC-Green) is a specialized diagnostic imaging agent with no inherent therapeutic effect on disease symptoms. Its primary benefit is providing real-time, objective visual data to guide critical clinical decisions, which may inform patient treatment.

The dye is indicated for determining cardiac output, hepatic function, liver blood flow, and for ophthalmic angiography as well as for fluorescence imaging during surgical procedures like visualization of blood flow, tissue perfusion, and lymph nodes.

Key Areas of Clinical Use

IC-Green is used across clinical settings marked by increased physiological stress to assess functional capacity, particularly in conditions involving the liver and heart. In relevant surgical contexts, it is applied during complex surgeries to enhance visualization of blood flow patterns and anatomical structures, such as in confirming tissue perfusion or locating sentinel lymph nodes. This application may be part of symptomatic management in situations where patients experience functional strain or require specialized imaging.

“The agent is relevant in conditions presenting with localized circulatory pathology, offering a diagnostic view that allows for the identification of complex vascular issues.”

This diagnostic process provides data that supports the planning of major surgery or the management of acute conditions, helping ease the potential overall symptom burden and contributing to improved comfort during symptomatic periods.

Quick Fact: Clarity for Functional Strain IC-Green helps address symptoms related to organ-specific functional stress by quantifying the remaining capacity of organs like the liver, which assists medical teams in planning appropriate management.

Official Eligibility and Contraindications for IC-Green Use

The eligibility for IC-Green is strictly defined by regulatory documents, focusing primarily on patient history, age, and specific physiological states. Use is permitted in adults and geriatric patients with no overall differences in safety or effectiveness noted between these groups.

Use during pregnancy and lactation is classified as conditional. For pregnant women, the medicine should be given only if clearly indicated due to a lack of adequate and well-controlled studies. Caution must be exercised when administering to a nursing mother.

Interactions with other medicines and products

The official regulatory interaction profile for Indocyanine Green (IC-Green) is structured around specific substance restrictions and documented changes to its pharmacokinetic clearance, as defined in government prescribing information.

Documented Pharmacokinetic Alterations

Several medications are listed in regulatory summaries as having a pharmacokinetic interaction that results in increased clearance of Indocyanine Green from the body, thereby reducing its plasma exposure. These interacting substances include Haloperidol, Nifedipine, Nitrofurantoin, and Phenobarbital.

Procedural and Timing Restrictions

Official labeling imposes specific restrictions related to the product’s composition and its use in diagnostic procedures:

• Laboratory Test Interference: Because IC-Green contains sodium iodide, radioactive iodine uptake studies should not be performed for at least one week following its administration to prevent interference with test results.
• Anticoagulant Restriction: Heparin preparations containing sodium bisulfite are restricted and should not be used as an anticoagulant for collecting blood samples intended for IC-Green analysis, as this substance interferes with the accurate photometric measurement of the dye.

Contraindication

The most stringent restriction is the formal contraindication for patients with a known history of hypersensitivity to Indocyanine Green.

Indocyanine Green is a tricarbocyanine dye that functions as a highly specific tracer based on its physiochemical properties and elimination route. When introduced into the circulation, the compound rapidly and near-completely binds non-covalently to plasma proteins, primarily albumin and globulins. This specific protein binding confines the molecule exclusively to the intravascular space, preventing extravasation into the interstitial fluid.

The molecule exhibits a maximum light absorption peak in the near-infrared (NIR) spectrum around 800, nm. Upon excitation, it undergoes fluorescence emission at a slightly longer wavelength, a molecular process leveraged for external detection.

Clearance is mediated almost entirely by the liver. The plasma-protein complex is extracted from the bloodstream by hepatocytes through a combination of passive diffusion and endocytosis. Critically, IC-Green is not chemically metabolized or conjugated within the liver. Following uptake, it is secreted, unaltered, into the bile and subsequently eliminated from the body via the biliary-fecal route without significant enterohepatic recirculation. The resulting system-level physiological consequence is that the dye's presence and rate of clearance directly reflect vascular patency and hepatic perfusion/excretory function.

Indocyanine Green (IC-Green) is a sterile, lyophilized green powder that must be reconstituted for use as an injectable diagnostic agent. Proper preparation and administration are critical for efficacy and patient safety.

Preparation and Reconstitution

The powder must be dissolved using the sterile water for injection provided in the kit under strict aseptic conditions. The resulting solution should be a clear, green color and is only stable for a limited duration. The reconstituted solution must be used within six hours of preparation and is for single-patient use only. Any unused product must be discarded after this period.

Routes and Dosing

IC-Green is primarily administered via intravenous (IV) injection but can also be given interstitially for specific procedures, such as lymphatic mapping. Dosage varies significantly based on the intended diagnostic procedure and patient characteristics, including weight.

For example, doses for indicator-dilution studies typically involve smaller amounts, such as 5.0 mg for adults and 1.25 mg for infants. In contrast, ophthalmic angiography may require doses up to 40 mg. The total dose administered should not exceed 2.0 mg/kg of body weight.

Administration Procedure

When administered intravenously, the dye is typically injected rapidly as a bolus. This injection should be immediately followed by a flush, such as a 10 mL bolus of 0.9% Sodium Chloride Injection, to ensure complete delivery of the dye. Because IC-Green is exclusively removed from the circulation by the liver and excreted into the bile, its presence and clearance are monitored via techniques like ear densitometry or blood specimen analysis, depending on the indication.

Research Evidence: Overview of Studies for IC-Green

Evidence for Visualization of Blood Flow and Tissue Perfusion (Angiography)

IC-Green was studied in the context of real-time visualization of blood flow and tissue health during major surgical procedures. Researchers used Randomized Controlled Trials (RCTs) and Systematic Reviews to explore its use in adult patients undergoing complex abdominal surgeries. Studies primarily monitored outcomes related to episodic or acute changes, such as rates of post-operative complications and the need for reoperation.

Research has explored whether the dye’s use in highlighting blood vessels was studied for its association with post-operative outcome measures. Findings describe patterns observed in the studies where surgeons used the dye to guide decisions. For certain specific procedures, some trials reported measurements related to complication rates that were observed in groups where ICG imaging was used. However, the evidence quality varies across studies, and some trials exploring its use in different anatomical locations reported mixed findings.

Evidence for Delineation of Lymphatic Structures (Lymphatic Mapping)

IC-Green was evaluated in studies focused on locating sentinel lymph nodes (SLNs) in specific cancer operations. Prospective Comparative Studies and Diagnostic Accuracy Meta-analyses were applied in research contexts involving adult patients with early-stage cancers. These studies focused on outcomes monitoring physiological strain or stress by measuring the successful detection rate of the sentinel lymph nodes and comparing the dye’s detection rates with those achieved with established tracers.

Studies reported detection rates for the lymph nodes that were examined alongside those achieved with established tracers. Research describes the dye’s capability to provide real-time visual guidance for surgeons in identifying the first draining lymph node. However, studies exploring short-term symptom changes suggest that its detection rates may vary depending on the specific type of cancer and where the tumor is located.

Evidence for Functional Assessment (Hepatic and Cardiac)

The earliest use of IC-Green was studied for determining liver function, liver blood flow, and cardiac output. The evidence for this application is based on historical foundational studies and contemporary observational settings evaluating daily-life functioning in patients requiring close monitoring. Studies primarily examined the dye’s pharmacokinetic parameters, such as the rate at which it is cleared by the liver, which serves as a biomarker for functional capacity.

Key Studies & References

1. Safety and Efficacy of Indocyanine Green in Colorectal Cancer Surgery: A Systematic Review and Meta-Analysis
2. Prediction of Survival After Partial Hepatectomy Using a Physiologically Based Pharmacokinetic Model of Indocyanine Green Liver Function Tests

Common questions about IC-Green (FAQ)

Q: What is the most serious potential side effect associated with the use of Indocyanine Green?

Official safety information for IC-Green highlights the potential for serious hypersensitivity reactions. These are severe allergic responses, including the risk of anaphylaxis and anaphylactic shock, which may be fatal. Due to this risk, official prescribing information notes that patients are monitored closely for signs of an allergic reaction during and after administration.

Q: Can IC-Green be used in children and infants?

According to regulatory documents, the use of IC-Green has been established in pediatric patients aged 1 month and older for certain fluorescence imaging procedures. However, the safety and effectiveness have not been established in infants younger than 1 month of age. A healthcare provider determines the appropriateness of use based on the patient’s age and indication.

Q: What is the exact chemical structure or formula of Indocyanine Green?

Indocyanine Green is a synthetic dye with a specific chemical composition. The official regulatory description states its chemical formula is C43 H47 N2 NaO6 S2. It is the active ingredient used in the diagnostic agent.

How to Store and Dispose of IC-Green

Official regulatory documents define the required conditions for storing and disposing of IC-Green (Indocyanine Green) to maintain its integrity and ensure safety.

Storage Conditions

Disposal Instructions

All unused portions of the reconstituted solution must be discarded.

Disposal must strictly comply with applicable local laws and regulations for pharmaceutical waste. The product should not be discharged to sewer systems or introduced into water sources.